i-131 iodocholesterol
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Dec 1, 1988 (NCT00037843)
Timeline
1980s
- Jan 1, 1988
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C[131I])[C@H]3CC[C@]12C- Mol. weight
- 516.56 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Imaging
- 131-iodine
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2105011 ↗
Also known as
- i-131 iodocholesterol
- iodocholesterol (131i)
- iodocholesterol (131i)
- iodocholesterol (131i)
- iodocholesterol (131i)
- iodocholesterol (131i)
- iodocholesterol i 131
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00037843 | Phase 3 | Dec 1, 1988 | University of Michigan, University of Texas at Houston |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Michigan | Academic/Hospital | 1 | 0 | 1 | 1988 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 1988 |
2 organizations
Page 1 / 1